Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...
Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...
Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...
TEANECK, N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ ...
Cognizant has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences that aims to unlock even greater value for Gilead as it advances innovations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results